The MacNew Heart Disease health-related quality of life instrument: a summary

Stefan Höfer, Lynette Lim, Gordon Guyatt, Neil Oldridge, Stefan Höfer, Lynette Lim, Gordon Guyatt, Neil Oldridge

Abstract

Background: The measurement of health, the effects of disease, and the impact of health care include not only an indication of changes in disease frequency and severity but also an estimate of patients' perception of health status before and after treatment. One of the more important developments in health care in the past decade may be the recognition that the patient's perspective is as legitimate and valid as the clinician's in monitoring health care outcomes. This has lead to the development of instruments to quantify the patients' perception of their health status before and after treatment.

Methods: We review evidence supporting the measurement properties of the MacNew Heart Disease Health-related Quality of Life [MacNew] Questionnaire which was designed to evaluate how daily activities and physical, emotional, and social functioning are affected by coronary heart disease and its treatment.

Results: Reliability was demonstrated by using internal consistency and the intraclass correlation coefficients for the three domains in the Dutch, English, Farsi, German, and Spanish versions of the MacNew. With internal consistency and intraclass correlation coefficients =>0.73, reliability is high. Validity of the MacNew was examined with factor analysis and three core underlying factors, physical, emotional, and social, were identified, explaining 63.0 - 66.5% of the observed variance and replicated in the translations with psychometric data. Construct validity of the MacNew was further demonstrated by extensive substantiation of the logical relationships, defined a priori, between items and other comparison tools. The MacNew is responsive and sensitive to changes in HRQL following various interventions for patients with heart disease with 11 of 13 effect size statistics >0.80. Taking an average of 10 minutes or less to complete, the respondent-burden for the MacNew is low and its acceptability is demonstrated by response rates of over 90%. Normative data are available for patients with myocardial infarction, angina, and heart failure in the English version.

Conclusion: The MacNew may be a valuable tool for assessing and evaluating health related quality of life in patients with heart disease.

References

    1. Geigle R, Jones SB. Outcomes measurement: a report from the front. Inquiry. 1990;27:7–13.
    1. Leplege A, Hunt S. The problem of quality of life in medicine. JAMA. 1997;278:47–50. doi: 10.1001/jama.278.1.47.
    1. Schipper H, Clinch J, Olweny CLM. Quality of life studies: Definitions and conceptual issues. In: Spilker B, editor. Quality of Life and Pharmacoeconomics in Clinical Trials [2nd edition] Philadelphia, Lippincott-Raven Publishers; 1996. pp. 11–23.
    1. Patrick DL, Erickson P. Health Status and Health Policy. Quality of Life in Health Care Evaluation and Resource Allocation. New York, Oxford University Press; 1993. pp. 1–478.
    1. Quality of life and clinical trials. Lancet. 1995;346:1–2.
    1. Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129–136.
    1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349:1498–1504. doi: 10.1016/S0140-6736(96)07492-2.
    1. Ware J E, Jr. The status of health assessment 1994. Annu Rev Public Health. 1995;16:327–354. doi: 10.1146/annurev.pu.16.050195.001551.
    1. Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Prodzinski J, McDonell M, Fihn SD. Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease. J Am Coll Cardiol. 1995;25:333–341. doi: 10.1016/0735-1097(94)00397-9.
    1. Rector TS, Kubo SH, Cohn JN. Patients' self-assessment of their congestive heart failure: Content, reliability, and validity of a new measure, the Minnesota Living with Heart Failure questionnaire. Heart Failure. 1987;3:198–209.
    1. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35:1245–1255. doi: 10.1016/S0735-1097(00)00531-3.
    1. Thompson DR, Jenkinson C, Roebuck A, Lewin RJ, Boyle RM, Chandola T. Development and validation of a short measure of health status for individuals with acute myocardial infarction: the Myocardial Infarction Dimensional Assessment Scale (MIDAS) Qual Life Res. 2002;11:535–543. doi: 10.1023/A:1016354516168.
    1. Guyatt GH, Jaeschke R, Feeny DH, Patrick DL. Measurement in clinical trials: Choosing the right approach. In: Spilker B, editor. Quality of Life and Pharmacoeconomics in Clinical Trials. Phildadelphia, Lippincott-Raven; 1996. pp. 41–48.
    1. Lim LL-Y, Valenti LA, Knapp JC, Dobson AJ, Plotnikoff R, Higginbotham N, Heller RF. A self-administered quality of life questionnaire after acute myocardial infarction. J Clin Epidemiol. 1993;46:1249–1256.
    1. Valenti L, Lim L, Heller RF, Knapp.J An improved questionnaire for assessing quality of life after myocardial infarction. Qual Life Res. 1996;5:151–161.
    1. Oldridge N, Guyatt G, Jones N, Crowe J, Singer J, Feeny D, McKelvie R, Runions J, Streiner D, Torrance G. Effects on quality of life with comprehensive rehabilitation after acute myocardial infarction. Am J Cardiol. 1991;67:1084–1089.
    1. Hillers TK, Guyatt GH, Oldridge N, Crowe J, Willan A, Griffith L, Feeny D. Quality of life after myocardial infarction. J Clin Epidemiol. 1994;47:1287–1296.
    1. Juniper EF, Guyatt GH, Streiner DL, King DR. Clinical impact versus factor analysis for quality of life questionnaire construction. J Clin Epidemiol. 1997;50:233–238. doi: 10.1016/S0895-4356(96)00377-0.
    1. Lim LL-Y, Johnson NA, O'Connell RL, Heller RF. Quality of life and later adverse health outcomes in patients with suspected heart attack. Aust NZ J Pub Health. 1998;22:540–546.
    1. Oldridge N, Gottlieb M, Guyatt G, Jones N, Streiner D, Feeny D. Predictors of health-related quality of life with cardiac rehabilitation after acute myocardial infarction. J Cardiopulm Rehabil. 1998;18:95–103. doi: 10.1097/00008483-199803000-00002.
    1. Brotons Cuixart C, Ribera Sole A, Permanyer Miralda G, Cascant Castello P, Moral Pelaez I, Pinar Sopena J, Oldridge NB. Adaptation of the MacNew QLMI quality of life questionnaire after myocardial infarction to be used in the Spanish population [in Spanish] Med Clin (Barc) 2000;115:768–771.
    1. Dixon T, Lim L, Oldridge NB. The MacNew health-related quality of life instrument: Reference data for users. Qual Life Research. 2002;11:173–183. doi: 10.1023/A:1015005109731.
    1. Höfer S, Benzer W, Schussler G, von Steinbuchel N, Oldridge NB. Health-related quality of life in patients with coronary artery disease treated for angina: validity and reliability of German translations of two specific questionnaires. Qual Life Res. 2003;12:199–212. doi: 10.1023/A:1022272620947.
    1. Asadi-Lari M, Javadi H, Melville M, Oldridge NB, Gray D. Adaptation and administration of the MacNew quality of life questionnaire after myocardial infarction in an Iranian population. Health and Qual Life. 2003;1:23 (01 Jul 2003).
    1. Benzer W, Höfer S, Oldridge NB. Health-related quality of life in patients with coronary artery disease after different treatments for angina in routine clinical practice. Herz. 2003;28:421–428. doi: 10.1007/s00059-003-2388-9.
    1. Höfer S, Benzer W, Brandt D, Laimer H, Schmid P, Bernardo A, Oldridge NB. Validation of the MacNew heart disease health-related quality of life questionnaire in German-speaking patients after myocardial infarction. Zeitschrift fuer klinische Psychologie.
    1. Heller RF, Knapp JC, Valenti LA, Dobson AJ. Secondary prevention after acute myocardial infarction. Am J Cardiol. 1993;72:759–762.
    1. Foster C, Oldridge NB, Dion W, Forsyth G, Grevenow P, Hansen MA, Laughlin J, Plitcha C, Rabas S, Sharkey RE, Schmidt DH. Time course of recovery during cardiac rehabilitation. J Cardiopulmon Rehabil. 1995;15:209–215.
    1. Heller RF, Lim L, Valenti L, Knapp J. A randomised controlled trial of community based counselling among those discharged from hospital with ischaemic heart disease. Aust NZ Med J. 1995;25:362–364.
    1. Heller RF, Lim L, Valenti L, Knapp J. Predictors of quality of life after hospital admission for heart attack or angina. Int J Cardiol. 1997;59:161–166. doi: 10.1016/S0167-5273(97)02946-X.
    1. Dixon T, Lim LL, Powell H, Fisher JD. Psychosocial experiences of cardiac patients in early recovery: a community-based study. J Adv Nurs. 2000;31:1368–1375. doi: 10.1046/j.1365-2648.2000.01406.x.
    1. McConnell TR, Laubach CA, Memon M, Gardner JK, Klinger TA, Palm RJ. Quality of life and self-efficacy in cardiac rehabilitation patients over 70 years of age following acute myocardial infarction and bypass revascularization surgery. Am J Geriatric Cardiol. 2000;9:210–218.
    1. Smith HJ, Taylor R, Mitchell A. A comparison of four quality of life instruments in cardiac patients: SF-36, QLI, QLMI, and SEIQoL. Heart. 2000;84:390–394. doi: 10.1136/heart.84.4.390.
    1. Dixon T, Lim LL, Heller RF. Quality of life: an index for identifying high-risk cardiac patients. J Clin Epidemiol. 2001;54:952–960. doi: 10.1016/S0895-4356(01)00368-7.
    1. Dempster M, Donnelly M, Fitzsimons D. Generic, disease-specific and individualised approaches to measuring health-related quality of life among people with heart disease - a comparative analysis. Psychol Health. 2002;17:447–457.
    1. McConnell TR, Mandak JS, Sykes JS, Fesniak H, Dasgupta H. Exercise training for heart failure patients improves respiratory muscle endurance, exercise tolerance, breathlessness, and quality of life. J Cardiopulm Rehabil. 2003;23:10–16. doi: 10.1097/00008483-200301000-00003.
    1. Gardner JK, McConnell TR, Klinger TA, Herman CP, Hauck CA, Laubach Jr CA. Quality of life and self-efficacy: Gender and diagnoses considerations for management during cardiac rehabilitation. J Cardiopulm Rehabil. 2003;23:299–306. doi: 10.1097/00008483-200307000-00007.
    1. Dijkers MP. Individualization in quality of life measurement: instruments and approaches. Arch Phys Med Rehabil. 2003;84:S3–14. doi: 10.1053/apmr.2003.50241.
    1. Medical Outcomes Trust Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res. 2002;11:193–205. doi: 10.1023/A:1015291021312.
    1. Hays RD, Anderson RT, Revicki D. Assessing reliability and validity of measurement in clinical trials. In: Staquet M J, Hays R D and Fayers PM, editor. Quality of Life Assessment in Clinical Trials: Methods and Practice. New York, Oxford University Press; 1998. pp. 169–182.
    1. Jaeschke R, Singer J, Guyatt GH. Ascertaining the minimal clinically important difference. Cont Clin Trials. 1989;10:407–415. doi: 10.1016/0197-2456(89)90005-6.
    1. Oldridge N, Perkins A, Marchionni N, Fumagalli S, Fattirolli F, Guyatt G. Number needed to treat in cardiac rehabilitation. J Cardiopulm Rehabil. 2002;22:22–30. doi: 10.1097/00008483-200201000-00003.
    1. Laupacis A, D Feeny, Detsky AS, Tugwell PX. Tentative guidelines for using clinical and economic evaluations revisited. Can Med Assoc J. 1993;148:927–929.
    1. Smith RF, Johnson G, Ziesche S, G Bhat, Blankenship K, Cohn JN. Functional capacity in heart failure. Circulation. 1993;87:VI–88-VI-93.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe